CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer.

অনুরূপ উপাদানগুলি

• CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer
  অনুযায়ী: Fenne L. Komdeur, অন্যান্য
  প্রকাশিত: (2017-09-01)
• Tumor infiltrating CD8/CD103/TIM-3-expressing lymphocytes in epithelial ovarian cancer co-express CXCL13 and associate with improved survival
  অনুযায়ী: Martijn Vlaming, অন্যান্য
  প্রকাশিত: (2022-10-01)
• Combined STING levels and CD103+ T cell infiltration have significant prognostic implications for patients with cervical cancer
  অনুযায়ী: Arjan Kol, অন্যান্য
  প্রকাশিত: (2021-01-01)
• A transcriptionally distinct CXCL13+ CD103+ CD8+ T-cell population is associated with B-cell 2 recruitment and neoantigen load in human cancer
  অনুযায়ী: Workel, H, অন্যান্য
  প্রকাশিত: (2019)
• Development of [89Zr]Zr-hCD103.Fab01A and [68Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET
  অনুযায়ী: Xiaoyu Fan, অন্যান্য
  প্রকাশিত: (2023-11-01)